You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

SODIUM FLUORIDE F-18 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for sodium fluoride f-18 and what is the scope of patent protection?

Sodium fluoride f-18 is the generic ingredient in three branded drugs marketed by Ge Healthcare, Nih Nci Dctd, 3d Imaging Drug, Bamf, Biomedcl Res Fdn, Cardinal Health 414, Decatur, Essential Isotopes, Hot Shots Nm Llc, Jubilant Draximage, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Nukemed, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, The Feinstein Inst, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Tx Md Anderson, and Univ Utah Cyclotron, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.

Ten suppliers are listed for this compound.

Summary for SODIUM FLUORIDE F-18
US Patents:0
Tradenames:3
Applicants:25
NDAs:26
Finished Product Suppliers / Packagers: 10
Raw Ingredient (Bulk) Api Vendors: 8
Clinical Trials: 121
Patent Applications: 29
What excipients (inactive ingredients) are in SODIUM FLUORIDE F-18?SODIUM FLUORIDE F-18 excipients list
DailyMed Link:SODIUM FLUORIDE F-18 at DailyMed
Recent Clinical Trials for SODIUM FLUORIDE F-18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Hong KongN/A
Universidade Federal do ParaPhase 3
Sun Yat-sen UniversityPhase 2

See all SODIUM FLUORIDE F-18 clinical trials

Pharmacology for SODIUM FLUORIDE F-18
Medical Subject Heading (MeSH) Categories for SODIUM FLUORIDE F-18

US Patents and Regulatory Information for SODIUM FLUORIDE F-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mips Crf SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 204517-001 Jul 21, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nukemed SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 203912-001 Apr 22, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ucsf Rodiopharm SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 204437-001 Mar 13, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hot Shots Nm Llc SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 204530-001 Jul 29, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Univ Utah Cyclotron SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 204497-001 Apr 20, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Kreitchman Pet Ctr SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 203936-001 May 19, 2016 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Midwest Medcl SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 204440-001 Nov 17, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.